Sesame Paste for Recurrent Aphthous Stomatitis
Sesame Paste in the Management of Recurrent Aphthous Stomatitis: a Randomized Controlled Trial.
1 other identifier
interventional
46
0 countries
N/A
Brief Summary
Oral recurrent aphthous stomatitis is a painful oral condition that affects large number of patients. In the Middle East, patients tend to commonly manage it by sesame paste. So, this study aims to test if sesame paste has any medical value compared to placebo.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable
Started Dec 2026
Typical duration for not_applicable
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
September 26, 2026
CompletedFirst Posted
Study publicly available on registry
October 1, 2026
CompletedStudy Start
First participant enrolled
December 1, 2026
ExpectedPrimary Completion
Last participant's last visit for primary outcome
December 1, 2027
Study Completion
Last participant's last visit for all outcomes
December 1, 2028
October 1, 2026
September 1, 2026
1 year
September 26, 2026
September 26, 2026
Conditions
Outcome Measures
Primary Outcomes (1)
Pain due to the oral ulcer
measured by VAS
7 days
Secondary Outcomes (1)
Size of the ulcer
7 days
Study Arms (2)
Sesame paste
ACTIVE COMPARATORPlacebo paste
PLACEBO COMPARATORInterventions
Sesame paste is available in grocery markets as "Tahina" or "Tahini"
Eligibility Criteria
You may qualify if:
- \- adult patients; diagnosed with having episodes of minor recurrent aphthous stomatitis around the age of puberty.
- the current episode of 1 to 3 simultaneous RAS lesions must have started for less than 24 hours.
You may not qualify if:
- \- patients who have any systemic disease or any extraoral lesions or manifestations.
- receiving any systemic medications in general, receiving analgesic mouthwash or systemic analgesic before 24 hours of starting the study.
- patients having allergy to sesame
Contact the study team to confirm eligibility.
Sponsors & Collaborators
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- QUADRUPLE
- Who Masked
- PARTICIPANT, CARE PROVIDER, INVESTIGATOR, OUTCOMES ASSESSOR
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR INVESTIGATOR
- PI Title
- PI
Study Record Dates
First Submitted
September 26, 2026
First Posted
October 1, 2026
Study Start (Estimated)
December 1, 2026
Primary Completion (Estimated)
December 1, 2027
Study Completion (Estimated)
December 1, 2028
Last Updated
October 1, 2026
Record last verified: 2026-09